Navigation Links
Virtify Launches Virtify SCM, A New Clinical Content Management Solution for the Life Science Industry
Date:6/24/2013

. Virtify SCM makes global regulatory compliance more routine, maximizing resources and producing more and better products in less time.

According to industry analyst firm IDC Health Insights, a new drug costs from $800 million to $1.2 billion to bring to market, and a quarter of this cost is content and regulatory requirements. Traditional document management approaches slow processes and isolate data. This promotes inefficiencies and risk in reporting, planning and regulatory affairs.

Benefits of Virtify SCM

Virtify SCM takes a new approach to managing clinical content to gain better insight into clinical operations. Benefits of Virtify SCM include:

  • Boosts Efficiency with Content Library. Virtify SCM leverages company content in a secure, searchable library of linked core data components. Content users receive notification when any applicable content is updated. Current regulatory forms and processes are also maintained. This master control facilitates accuracy and accountability of content assets and their growth, while reducing infrastructure.
  • Reduces Time and Cost with Document Automation. Virtify SCM maximizes the reuse of core structured data and regulatory templates to build submission, labels and other documents on demand. Submission and electronic sign-off requirements are noted.
  • Enhances Collaboration with Parallel Authoring. The content management and collaboration tools enable authorized workers to collaborate with a document in real time to better manage complex, multi-submission compliance requirements.
  • Better Accountability with Content Tracking. Virtify SCM records variations from master content and tracks its evolution and lineage. All changes and sources are inventoried, and the document is tracked to the final submitted form.
  • Ease of Use - Work the Way You Want. SCM uses a Microsoft® Word para
    '/>"/>

SOURCE Virtify, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
3. Mylan Launches Generic Version of Zyprexa® Tablets
4. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
5. American Academy of Family Physicians Foundation Launches Cities for Life
6. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
7. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
8. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
9. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
10. Practice Fusion Launches API to Democratize Lab Integrations
11. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... R.I. , Jan. 15, 2014 MultiCell Technologies, ... filed a U.S. provisional patent application concerning composition of ... to achieve targeted tumor cell death.  ... small noncoding double stranded RNA molecules (VSRNAs) which interfere ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... novel wearable injector slightly larger than an Oreo cookie may ... prescription drugs in the large doses required to treat a ... and genetic disorders.  An emerging biologic drugs ... to analysts.   Many of these drugs will require a new ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... April issue of Experimental Biology and Medicine ... Rex Gaskins and Paul Kenis in the Institute ... the University of Illinois Urbana-Champaign describe their recent ... underlie a variety of cell functions including energy ... crucial roles in regulating normal cellular behavior, redox ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... to ward off depression among retirees, particularly among those ... The Journals of Gerontology, Series B: Psychological ... " Internet Use and Depression Among Retired Older Adults ... authors report that Internet use reduced the probability of ... sample. , Late-life depression affects between 5 and ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Internet use may cut retirees' depression 2
... group based in Washington, D.C., has been working to,prevent ... on,the food chain is the primary way that we ... neurological and other health problems., In honor of ... tips for keeping your family mercury-free (and worry-free):, ...
... in fried foods, snacks, coffee upped chances of disease ... large amounts of acrylamide, a chemical commonly found in ... raise the risk of kidney cancer, especially in smokers, ... of a positive association between dietary acrylamide intake and ...
... Surface and Volume ... ... a global innovator of simulation software and technologies designed,to optimize product ... advanced mesh generation software. TGrid,technology is a specialized pre-processor for fluid ...
... May 9, 2008 More than 4,000 infection ... are expected to convene at a five-day conference ... issues facing their profession today. , Strategies for ... of healthcare-associated infections (HAIs) and emerging multidrug-resistant bacteria ...
... BIRMINGHAM, Ala., May 8 HealthSouth,Corporation (NYSE: HLS ... among other things, elect directors and provide an update ... May 2007., More than 88.5% of the outstanding ... in person or by proxy and the board,s,nominated slate ...
... Effort includes updated Web pages, brochure, advertisement, and,informational ... ROCKVILLE, Md., May 8 On May 8, ... launch a,nationwide outreach effort to raise awareness about ... near nuclear weapons testing facilities in,the mid-20th century. ...
Cached Medicine News:Health News:Amber Valletta on Preventing Mercury Exposure 2Health News:Amber Valletta on Preventing Mercury Exposure 3Health News:Acrylamide Raises Kidney Cancer Risk 2Health News:Acrylamide Raises Kidney Cancer Risk 3Health News:TGrid 5.0 Advances Automatic, High-Quality Meshing Tools for Increased Productivity 2Health News:TGrid 5.0 Advances Automatic, High-Quality Meshing Tools for Increased Productivity 3Health News:APIC conference to focus on patient safety and 'Targeting Zero' initiatives to reduce HAIs 2Health News:HealthSouth Board Re-Elected at Annual Shareholder Meeting 2Health News:HRSA Outreach Seeks to Raise Cancer Awareness Among People Who Lived Near Nuclear Sites or Mined Uranium 2Health News:HRSA Outreach Seeks to Raise Cancer Awareness Among People Who Lived Near Nuclear Sites or Mined Uranium 3
... unique DHEA-S-7kits feature a ... against the C-7 position ... with no cross-reactivity with ... RIA has been optimized ...
... based on the competition principle and the ... present in the sample and a fixed ... compete for the binding sites of a ... After one hour incubation the microtiterplate is ...
Inquire...
... It is a compact Latex based reagent kit ... well as to determine the level of RF ... patient sera. The kit includes antigen coated fine ... control sera in plastic squeezable dropping bottles, re-usable ...
Medicine Products: